Melanoma Diagnostics

Melanoma Diagnostics Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Melanoma Diagnostics General Information

Description

Developer of molecular diagnosis technologies. The company's molecular diagnosis technologies includes a number of highly validated genetic markers, allowing it to discriminate between normal and melanoma (cancer) cells, enabling pathologists to discriminate between benign moles and melanoma and to better characterize the risk of disease progression or metastasis.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Acquirer
Primary Office
  • 2400 North Lincoln Avenue
  • Altadena, CA 91001
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Melanoma Diagnostics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Melanoma Diagnostics‘s full profile, request access.

Request a free trial

Melanoma Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Kevin Scanlon Chief Executive Officer
Kashani Sabet Founder